Reply to M.C. Chamberlain

J Clin Oncol. 2014 May 20;32(15):1634-5. doi: 10.1200/JCO.2013.54.9717. Epub 2014 Apr 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Brain Neoplasms / drug therapy*
  • Dacarbazine / analogs & derivatives*
  • Female
  • Glioblastoma / drug therapy*
  • Humans
  • Male

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine